title: Long-lasting drop in perfusion of a non-small cell lung cancer induced by monotherapy with the epithelial growth factor receptor inhibitor erlotinib persisting despite tumor progression at remote sites.
authors.affiliation: Department of Radiology, Eberhard-Karls-University Tuebingen, Tuebingen, Germany.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Schulze
authors.forename: Werner
authors.initials: W
authors.lastname: Spengler
authors.forename: Marius
authors.initials: M
authors.lastname: Horger
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000098:blood supply / Q000188:drug therapy* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors